Vitality Watch

Dossier pubmed preclinical 15-sep-2026
Animal model, organoid, or cell-culture result — not yet human

LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging.

Key claim: LSD1 demethylates ATM at lysine 3016 to sustain DNA-damage signaling and promote cellular senescence and organ aging, while LSD1 inhibition enhances repair, reduces senescence, and prevents irradiation-induced hair graying.

Abstract

Aging occurs heterogeneously across organs, leading to progressive tissue dysfunction. Cellular senescence is a stress response triggered by age-associated insults, yet the mechanisms regulating senescence and organ aging remain incompletely understood. Here, we defined a role for lysine-specific demethylase 1 (LSD1) in DNA damage-mediated senescence and organ aging. LSD1 was upregulated in aged organs and senescent cells. In response to natural aging or ionizing radiation-induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, as confirmed using a newly generated ATM-K3016me antibody. This modification sustained ATM phosphorylation, amplified DNA damage signaling, and delayed checkpoint recovery, promoting senescence and organ aging. Inhibition of LSD1 accelerated ATM dephosphorylation via WIP1, enhanced DNA repair, reduced senescence and DNA damage, and prevented irradiation-induced hair graying. Elimination of senescent cells with senolytics reduced LSD1 protein in aged organs, indicating a feedback loop between LSD1 and senescence. Mechanistically, LSD1 underwent autophagosome-lysosome degradation through interaction with LC3 and Beclin1, and autophagy impairment during DNA damage contributed to LSD1 accumulation in senescent cells. This study revealed LSD1 as a key regulator of DNA damage-induced senescence and organ aging and suggested that targeting LSD1 may attenuate senescence, delay organ aging, and prevent hair graying.

Why this matters

ATM has been treated as a sensor whose activation is set by DNA lesions; positioning LSD1-mediated K3016 demethylation as a sustaining input reframes chronic DDR signaling in aged cells as an epigenetically-regulated state rather than a purely damage-driven one. If it holds, this places a lysine demethylase upstream of both the senescence program and its autophagy-dependent clearance, and gives one hair-graying phenotype as a visible preclinical readout — but the entire causal chain is mouse/cell, with the usual translation gap to any human LSD1-inhibitor claim.

Source

Link

Briefing card

LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging.
Stage: preclinical · pubmed · 15-sep-2026

If you are tracking LSD1 inhibitors as a longevity candidate, this preclinical work identifies the LSD1–ATM K3016 axis as their proposed mechanism for reducing senescence and preventing radiation-induced hair graying — with no human outcome data yet.

LSD1 demethylates ATM at lysine 3016 to sustain DNA-damage signaling and promote cellular senescence and organ aging, while LSD1 inhibition enhances repair, reduces senescence, and prevents irradiation-induced hair graying.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1172/JCI199854

build build 880 · 2bcef25 · 2026-11-18